References
- Kazi A, Smith DM, Daniel K, Zhong S, Gupta P, Bosley ME. 2002. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo 16: 397-403.
- Yang CS, Wang X. 2010. Green tea and cancer prevention. Nutr Cancer 62: 931-937. https://doi.org/10.1080/01635581.2010.509536
- Lambert JD, Elias RJ. 2010. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65-72. https://doi.org/10.1016/j.abb.2010.06.013
- Gupta S, Hussain T, Mukhtar H. 2003. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cells cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410: 177-185. https://doi.org/10.1016/S0003-9861(02)00668-9
- Jun YD, Ellis LM. 2001. Inhibition of tumour invasion and angiogenesis by epigallocatechin galltae (EGCG), a major component of green tea. Int J Exp Pathol 82: 309-316.
- Matsuyama R, Reddy S, Smith TJ. 2006. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24: 3490-3496. https://doi.org/10.1200/JCO.2005.03.6236
- Bartelink H, Schellens JH, Verheij M. 2002. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 38: 216-222. https://doi.org/10.1016/S0959-8049(01)00363-X
- Samad A, Sultana Y, Aqil M. 2007. Liposomal drug delivery systems: an update review. Curr Drug Deliv 4: 297-305. https://doi.org/10.2174/156720107782151269
- Di Stefano G, Fiume L, Baglioni M, Bolondi L, Busi C, Chieco P, Kratz F, Manaresi F, Pariali M. 2006. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade. Liver Int 26: 726-733. https://doi.org/10.1111/j.1478-3231.2006.01289.x
- Kanadaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. 2005. The antitumor activities of flavonoids. In Vivo 19: 895-909.
- Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved MTT assay. J Immunol Methods 157: 203-207. https://doi.org/10.1016/0022-1759(93)90088-O
- Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245: 232-41. https://doi.org/10.1016/j.canlet.2006.01.027
- Rao SD, Pagidas K. 2010. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Res 30: 2519-2523.
- Silverberg JI, Jagdeo J, Patel M, Siegel D, Brody N. 2011. Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis. J Drugs Dermatol 10: 1096-1101.
- Crown JP. 2001. The platinum agents: a role in breast cancer treatment? Senmin Oncol 28: 28-37.
- Jordan P, Carmo-Fonseca M. 2000. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57: 1229-1235. https://doi.org/10.1007/PL00000762
- Cersosimo RJ. 1993. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharmacother 27: 438-441.
- Chan MM, Soprano KJ, Weinstein K, Fong D. 2006. Epigallocatechin- 3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol 207: 389-396. https://doi.org/10.1002/jcp.20569
Cited by
- Antioxidant and Tyrosinase Inhibitory Effects of the Extract Mixtures of Perilla frutescens, Houttuynia cordata and Camellia sinensis vol.41, pp.2, 2015, https://doi.org/10.15230/SCSK.2015.41.2.173